openPR Logo
Press release

Infection Control Market Size, Share, Growth Analysis, and Report 2024-2031

09-09-2024 02:34 PM CET | Health & Medicine

Press release from: DataM Intelligence 4Market Research

Infection Control Market || 2024-2031

Infection Control Market || 2024-2031

Infection Control Market is estimated to reach at a CAGR of 4.60% during the forecast period 2024-2031.

Infections are primarily caused by microorganisms like bacteria, viruses, and fungi. They can manifest in various forms, including Hospital Acquired Infections (HAIs), stomach and intestinal infections, eye infections, ear infections, lung and respiratory infections, skin infections, and sexually transmitted infections. These infections often result from cross-contamination via equipment, surfaces, or direct contact with the skin of patients and healthcare staff. Infection prevention and control measures are essential for mitigating the spread of infectious diseases. Major HAIs include ventilator-associated pneumonia, bloodstream infections, and catheter-associated urinary tract infections (UTIs).

Get a Free Sample Research PDF: https://www.datamintelligence.com/download-sample/in-vitro-diagnostics-market

Market Dynamics:

Rise in technological advancements

Technological advancements are significantly contributing to the growth of the IVD market during the forecast period. Molecular diagnostics, such as PCR and NGS, enable early detection of genetic diseases, enhancing diagnostic accuracy and treatment outcomes. Point-of-care testing devices facilitate quicker diagnoses and treatments, particularly in remote areas. Automation and digitalization in IVD systems boost efficiency, minimize human error, and deliver more accurate results, especially in remote settings. The introduction of novel and highly accurate clinical laboratory tests is driving the global adoption of innovative IVD tests. For example, in June 2023, Toray Industries, Inc. obtained marketing approval from Japan's Ministry of Health, Labour and Welfare for its Toray APOA2-iTQ, a diagnostic tool for pancreatic cancer. Additionally, in March 2023, Abbott received U.S. FDA clearance for its new traumatic brain injury (TBI) blood test. The increasing approval of IVD tests for life-threatening diseases is expected to open new opportunities in previously untapped markets.

Segment Covered in the Infection Control Market:

By Product Type: Disinfection products, Sterilization Products, Packaging Accessories, Protective Barriers, Endoscope Reprocessing Products, Others.

By End-User: Hospitals, Ambulatory Surgical Centers, Others

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/infection-control-market

Key players involved in Infection Control Market:

• Getinge AB
• STERIS plc
• Advanced Sterilization Products
• 3M Company
• Belimed AG
• Cantel Medical Corporation
• MMM Group
• Matachana Group
• Sotera Health LLC
• Metrex Research Corporation

Related Reports:

Surgical Lighting System Market: https://www.datamintelligence.com/research-report/surgical-lighting-system-market

Hospital Commode Market: https://www.datamintelligence.com/research-report/hospital-commode-market

Surgical Clips Market: https://www.datamintelligence.com/research-report/surgical-clips-market

Regional Analysis:

The Infection Control Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa. The report offers detailed insight into new product launches, new technology evolutions, innovative services, and ongoing R&D. The report discusses a qualitative and quantitative market analysis, including PEST analysis, SWOT analysis, and Porter's five force analysis. The Infection Control Market report also provides fundamental details such as raw material sources, distribution networks, methodologies, production capacities, industry supply chain, and product specifications.

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Infection Control Market Size, Share, Growth Analysis, and Report 2024-2031 here

News-ID: 3649708 • Views:

More Releases from DataM Intelligence 4Market Research

United States Peripheral Neuropathy Market Set for Transformative Growth with Rising Treatment Innovations 2025 | Top key players - GlaxoSmithKline, Abbott Laboratories, Cipla Laboratories.
United States Peripheral Neuropathy Market Set for Transformative Growth with Ri …
Market Size and Growth: The Peripheral Neuropathy Market size was valued US$ 1,539 million in 2021 and is estimated to reach US$ YY million by 2031, growing at a CAGR of 4.2% during the forecast period (2024-2031). The Peripheral Neuropathy Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market participants
United States Acute Coronary Syndrome Market Set for Robust Growth with Advancements in Treatment & Rising Cardiovascular Cases 2025 | Top key players - Merck, Novartis, Amgen Inc.
United States Acute Coronary Syndrome Market Set for Robust Growth with Advancem …
Market Size and Growth: The Global Acute Coronary Syndrome Market size reached US$ 9.94 billion in 2023 and is expected to reach US$ 14.70 billion by 2031, growing at a CAGR of 5.1% during the forecast period 2024-2031. The Acute Coronary Syndrome Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for
United States Atrial Fibrillation Market Surges with Breakthrough Therapies and Rising Patient Demand 2025 | Top key players - AdvaCare Pharma, Sanofi, Pfizer Inc.
United States Atrial Fibrillation Market Surges with Breakthrough Therapies and …
Market Size and Growth: The Global Atrial Fibrillation Market size reached US$ 26.75 billion in 2024 and is expected to reach US$ 63.79 billion by 2033, growing at a CAGR of 10.6 % during the forecast period 2025-2033. The Atrial Fibrillation Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market
United States Personalized Cancer Vaccines Market Set for Breakthrough Growth with Innovative Therapies Revolutionizing Oncology Care 2025 | Major key players - BioNTech SE, Merck & Co., Inc., Moderna, Inc.
United States Personalized Cancer Vaccines Market Set for Breakthrough Growth wi …
Market Size and Growth: The Global Personalized Cancer Vaccines Market size reached US$ 11.33 Billion in 2024 from US$ 10.21 Billion in 2023 and is expected to reach US$ 30.12 Billion by 2033, growing at a CAGR of 11.5% during the forecast period 2025-2033. The Personalized Cancer Vaccines Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in

All 5 Releases


More Releases for Infection

Growing Hospital-Acquired Infection Rates Boost Demand For Infection Prevention …
The Infection Prevention Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Projected Growth of the Infection Prevention Market? In the past few years, there has been a consistent increase in the size of the infection prevention market. It is predicted that this market
Prominent Infection Prevention Market Trend for 2025: Strategic Staffing Innovat …
What Are the Projected Growth and Market Size Trends for the Infection Prevention Market? The infection prevention market is expected to grow from $43.4 billion in 2024 to $45.01 billion in 2025, reflecting a CAGR of 3.7%. Growth drivers include increasing awareness of healthcare-associated infections (HAIs), stringent regulatory guidelines, technological advancements, and globalization. The Infection Prevention market is expected to grow to $52.2 billion by 2029 at a CAGR of 3.8%, driven
Yeast Infection Treatment Market Report 2024 - Yeast Infection Treatment Market …
"The Business Research Company recently released a comprehensive report on the Global Yeast Infection Treatment Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. According to The Business Research Company's, The yeast infection
Combating Infection: Nontuberculous Mycobacterial Infection Market Analysis 2024 …
The nontuberculous mycobacterial infection market size has grown strongly in recent years. It will grow from $13.43 billion in 2023 to $14.25 billion in 2024 at a compound annual growth rate (CAGR) of 6.1%. The growth in the historic period can be attributed to improved diagnostics, aging population, cystic fibrosis awareness, immunosuppressive medications. The nontuberculous mycobacterial infection market size is expected to see strong growth in the next few
Infection Surveillance Solutions Market: Empowering Infection Prevention | BD, B …
Allied Market Research analysts have recently introduced a new research study titled "Infection Surveillance Solutions Market- Global Outlook and Forecast 2023-2030." The report offers detailed insights and highlights key players in the industry, including Atlas Medical Software, Becton, Dickinson and Company, Baxter International, GOJO Industries, Deb Group, RL Solutions, HyGreen, Wolters Kluwer, Premier, and Truven Health Analytics. This comprehensive study provides in-depth and clear analysis, encompassing market definitions, classifications, manufacturing
Infection Prevention & Control Market 2026: Product Overview and Scope of Infect …
Infection Prevention & Control Market Research Report and Forecast to 2019-2026 Report provide an extensive research on the fast-evolving Infection Prevention & Control Market. It also gives competitive landscape of the leading companies with regional and Global analysis of the market till 2026. The report mainly studies the size, recent trends and development status of the Infection Prevention & Control market, as well as investment opportunities, government policy, market dynamics (drivers,